Notice: Private records are filtered that would not be displayed.
Sort:
  • PROJ WGS of PDC

    Peiwei Chai, Shanghai Ninth people's hospital,2024.04.10

    Description

    The WGS of PDC with hydroxyurea of treatment

    OEP005197

  • PROJ Circle-seq of the retinoblastoma tissues and normal controls

    Peiwei Chai, Shanghai Ninth people's hospital,2024.04.10

    Description

    OEP005199

  • PROJ WGS of the normal controls (retina tissues)

    Peiwei Chai, Shanghai Ninth people's hospital,2024.04.12

    Description

    The cohort includes 5 samples

    OEP005203

  • PROJ WGS of the retinoblastoma

    Peiwei Chai, Shanghai Ninth people's hospital,2024.04.07

    Description

    This cohort includes 20 patients.

    OEP005189

  • PROJ QC_ZY

    Zheng Lab, Fudan univerisity,2024.04.12

    Description

    OEP005206

  • PROJ RG cohort

    Chenfen Zhou, PICB,2020.12.17

    Description

    OEP001391

  • PROJ Identification of a Defensive Niche Cell Population Expressing Gremlin1 in the Spleen to Restrain Chronic Myeloid Leukemia

    HelenHe Zhu, State Key Laboratory of Oncogenes and Related Genes, Renji‐Med‐X Stem Cell Research Center, Department of Urology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China,2022.09.16

    Description

    The spleen plays a critical role in the pathogenesis of leukemia. However, our understanding of the splenic niche in regulating leukemic cells is very limited. Herein, we report identification of such a unique splenic niche population. Induced expression of a secreted protein Gremlin1 in a genetically engineered mouse model restrains the disease progression of chronic myeloid leukemia (CML) and synergizes with first-line tyrosine kinase inhibitor (TKI) treatment, whereas blockade of the Gremlin1 protein by a monoclonal antibody enhances the CML development. Intriguingly, the CML-promoting effect of anti-Gremlin1 antibody is most evident in the spleen but not in the bone marrow, which can be abrogated by splenectomy. Genetic ablation of Gremlin1+ cells leads to an accelerated CML progression. Together with analysis of single cell RNA-seq data, we find that Gremlin1 marks a unique stromal cell population in the spleen of not only mice, but also humans. Mechanistically, Gremlin1 induces apoptosis of leukemia stem cells (LSCs) via antagonizing the BMP pathway. Together, we demonstrate that Gremlin1 and Gremlin1+ cells are key defensive niche components in the spleen to limit the progression of CML, revealing an unprecedented mechanism for the body to fight off leukemia.

    OEP003642

  • PROJ Metabolomic insights reveal pathogenesis and therapeutic potential in adult acute lymphoblastic leukemia

    Tuantuan Gui, Shanghai JiaoTong University,2024.03.25

    Description

    Acute lymphoblastic leukemia (ALL) poses formidable challenges in adult patients, considering its heterogeneous nature and relatively unfavorable prognosis among hematological malignancies.The metabolic interplay between body organs and bone marrow (BM) in ALL remains poorly understood, with limited knowledge beyond BM microenvironment in promoting ALL or how the body responds.

    OEP005155

  • PROJ 测试项目

    Luo Ruijin, ,2023.11.09

    Description

    武汉开发部分-测试提交

    OEP004707

  • PROJ 测试删除项目

    Luo Ruijin, ,2024.04.09

    Description

    OEP005194